The global drug screening market is
projected to reach USD 11.6 billion by 2026, from USD 5.3 billion in 2021, at a
CAGR of 16.8% during the forecast period. Growth in this market is attributed
to the growing drug & alcohol consumption and the enforcement of stringent
laws mandating drug & alcohol testing, rising regulatory approvals for drug
screening products & services. The rising drug & alcohol consumption,
the enforcement of stringent laws mandating drug and alcohol testing,
government funding in major markets, and regulatory approvals and product and
service launches are the major factors driving the growth of this market.
Access Sample Copy of the Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=162987773
North America to dominate the drug
screening market in 2020.
In 2020, North America is expected to
dominate the market with a share of 48.2%, followed by Europe. The large share
of this geographical segment is attributed to factors such as growing
consumption of illicit drugs, the availability of government funding to curb drug
abuse, laws supporting drug screening, the growing burden of accidents due to
alcohol impairment, and the presence of key players in the region are driving
the growth of the drug screening market in this region.
The drug screening market is highly competitive
with the presence of several small and big players. Some of the players
offering products for drug screening market include Abbott Laboratories (US),
Thermo Fisher Scientific (US), Quest Diagnostics (US), Alfa Scientific Designs
(US), Roche (Switzerland), OraSure Technologies (US), MPD Inc. (US), and
Shimadzu (Japan).
Services segment is expected to grow at
the highest CAGR during the forecast period.
Based on service and product, the drug
screening market is segmented into services and products. The services segment
accounted for the largest share of 57.4%
of the drug screening market in 2020. This segment is also expected to
register the highest CAGR during the forecast period, mainly due to the growing
drug & alcohol consumption worldwide, funding initiatives for drug testing
laboratories, service launches and regulatory approvals, and geographic
expansion of drug testing laboratories.
Analytical instruments are expected to
dominate the drug screening products market in 2020.
Based on the product, the drug screening
market is segmented into analytical instruments, rapid testing devices, and
consumables. In 2020, the analytical segment is expected to dominate the market
with a share of 53.0%. The high growth in this segment is owing to their
recurring requirement and repetitive usage.
Based on the sample type, the urine
sample segment is accounted for the largest share of the drug screening market.
By sample type, drug screening market is
segmented into urine, breath, oral fluid, hair, and other samples. Among these,
the urine sample segment is expected to account for the largest share of 61.5%
in 2020. The high growth of this segment is attributed due to the benefits it
offers such as easy collection method, high accuracy in the detection of
multiple drugs, cost-effectiveness, and instant results.
Don’t miss out on business opportunities
in Drug Screening Market. Speak to our analyst and gain crucial industry
insights that will help your business grow.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B
research on 30,000 high growth niche opportunities/threats which will impact
70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers
worldwide including 80% of global Fortune 1000 companies as clients. Almost
75,000 top officers across eight industries worldwide approach MarketsandMarkets™
for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at
MarketsandMarkets™ are tracking global high growth markets following the
"Growth Engagement Model – GEM". The GEM aims at proactive
collaboration with the clients to identify new opportunities, identify most
important customers, write "Attack, avoid and defend" strategies,
identify sources of incremental revenues for both the company and its
competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants
(Positioning top players across leaders, emerging companies, innovators,
strategic players) annually in high growth emerging segments.
MarketsandMarkets™ is determined to benefit more than 10,000 companies this
year for their revenue planning and help them take their
innovations/disruptions early to the market by providing them research ahead of
the curve.
MarketsandMarkets’s flagship competitive
intelligence and market research platform, "Knowledgestore" connects
over 200,000 markets and entire value chains for deeper understanding of the
unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com